MTVA MetaVia Inc.
Company Analysis
Latest News
🔴 MetaVia is trading 6.09% down today in after-hours trading
MetaVia is trading 6.09% down at $1.62 after-hours on September 18, 2026, and no clear company-specific announcement, earnings release, or late-breaking...
🟢 MetaVia is trading 5% up today
MetaVia is trading 5.06% higher at $1.66, with no clear company-specific catalyst identified for September 18, 2026. - The latest identifiable company news...
🟢 MetaVia is trading 5% up in pre-market with broader risk-on sentiment likely driving gains
MetaVia is trading 5.06% up at $1.66, likely driven by broader risk-on sentiment; no fresh company-specific announcement, earnings release, or analyst action...
🟢 MetaVia is trading 8.27% up in pre-market amid broader risk-on sentiment
MetaVia is trading 8.27% up at $1.67, apparently amid broader risk-on pre-market sentiment. - It closed at $1.54 on September 16, 2026. - No new...
🟢 MetaVia is trading 5.47% up today in pre-market; catalyst unclear
MetaVia is trading 5.47% up in pre-market at $1.67 after closing at $1.58 on September 15, 2026, but the catalyst remains unclear. - No confirmed September 16...
🟢 MetaVia is trading 5.59% up in after-hours trading; catalyst unclear
MetaVia is trading at $1.67, up 5.59% in after-hours trading, with no confirmed company-specific catalyst identified. - It closed at $1.58 on September 15,...
🟢 MetaVia is trading 6% up today in pre-market as catalyst remains unclear
MetaVia is trading 5.88% up now at $1.72, after rising from the September 14 close of $1.62; the catalyst remains unclear pending additional overnight...
🔴 MetaVia is trading 5% down in pre-market amid broader risk-off sentiment
MetaVia is trading 5.42% down in pre-market at $1.57, amid broader risk-off sentiment pressuring equities. - MetaVia declined 5.14% to $1.66 on September...
🔴 MetaVia is trading 5% down today — no clear catalyst identified
MetaVia is trading 5.14% down now at $1.66, with no credible company-specific catalyst identified. - No credible September 11, 2026 company-specific...
MetaVia's Fat-Targeting Drug Data Lifts a $10 Million Micro-Cap — But Can Preclinical Science Bridge the Gap to a Crowded Obesity Market?
Shares of MetaVia (MTVA) jumped 7.6% to $1.83 on September 9 after the company released preclinical findings showing its lead obesity drug concentrates most...
🟢 MetaVia is trading 7.65% up today after DA-1726 showed highest exposure in adipose tissue
MetaVia is trading 7.65% up now at $1.83 after preclinical results showed DA-1726 was broadly distributed, with the highest tissue exposure in adipose...
🔴 MetaVia is trading 6.18% down today with no clear catalyst identified
MetaVia is trading 6.18% down at $1.59, reversing its September 8 close of $1.70, with no clear catalyst identified. - No company-specific announcement,...
🟢 MetaVia is trading 5.46% up in pre-market with no clear catalyst identified
MetaVia is trading 5.46% up at $1.79 in pre-market, with no clear company-specific catalyst identified for September 9, 2026. - The latest company update was...
🟢 MetaVia is trading 5% up in pre-market; catalyst unclear
MetaVia is trading 5.39% up at $1.84 in pre-market, based on the provided data, while the catalyst remains unclear. - No fresh company-specific announcement...
🟢 MetaVia is trading 5.7% up in after-hours trading with no confirmed company-specific catalyst
MetaVia is trading at $1.85, up 5.7% after-hours after closing at $1.75 on September 4, 2026, with no confirmed company-specific catalyst identified. - Its...
🔴 MetaVia is trading 7.61% down today — no clear company-specific announcement identified
MetaVia is trading 7.61% down at $1.70, with no clear company-specific announcement identified for September 4, 2026. - MetaVia’s investor-relations page...
🟢 MetaVia is trading 5.5% up today with no clear company-specific catalyst
MetaVia is trading 5.5% up at $1.92 after no clear company-specific catalyst emerged for September 03, 2026, with the move appearing aligned with broader risk...
🔴 MetaVia is trading 7.68% down in after-hours trading with no clear company-specific catalyst identified
MetaVia is trading 7.68% down at $1.68 after no clear company-specific catalyst was identified for September 2, 2026. - The investor-relations page lists...
🟢 MetaVia is trading 5.8% up today with no clear catalyst
MetaVia is trading 5.8% up now at $1.82, with no clear catalyst identified. - No company-specific announcement, filing, analyst action, or other clear...
🔴 MetaVia is trading 5% down in pre-market; no clear company-specific catalyst identified
MetaVia is trading at $1.63, down 5.23%, with no clear company-specific catalyst identified for September 1, 2026. - Investor relations lists August 6 as the...